CG Oncology, Inc Common stock
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $43 | $111 | $529 | $1 |
Gross Profit | 43 | 104 | 525 | -3 |
EBITDA | -28,274 | -25,853 | -22,465 | -18,928 |
EBIT | -28,295 | -25,860 | -22,469 | -18,932 |
Net Income | -20,405 | -18,902 | -16,932 | -16,116 |
Net Change In Cash | 43 | 111 | 529 | 1 |
Free Cash Flow | -15,918 | -16,134 | -26,024 | -16,061 |
Cash | 43,411 | 25,158 | 77,468 | 8,266 |
Basic Shares | 67,143 | 66,649 | 47,064 | 66,636 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
Revenue | $204 | $191 | $10,358 |
Gross Profit | -45,548 | 176 | 10,348 |
EBITDA | -55,432 | -35,231 | -12,378 |
EBIT | -55,449 | -35,246 | -12,388 |
Net Income | -48,607 | -35,443 | -12,839 |
Net Change In Cash | 204 | 191 | 10,358 |
Free Cash Flow | -45,679 | -29,818 | -13,751 |
Cash | 8,266 | 88,143 | 53,607 |
Basic Shares | 4,330 | 66,636 | 66,636 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.28 |
2024-03-31 | -$0.36 |
2023-12-31 | -$0.33 |
